BioCardia, Inc. (BCDA) reporting calendar
BioCardia, Inc. files periodic reports with the SEC as BCDA on Nasdaq. Atlas tracks 75 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 23 Jul 2026 – 3 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 15 May 2026
- Reports on record
- 75
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open BCDA market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 15 May 2026 | 45 days | 0001437749-26-017221 |
| 10-K | 31 Dec 2025 | 24 Mar 2026 | 83 days | 0001437749-26-009587 |
| 10-Q | 30 Sep 2025 | 12 Nov 2025 | 43 days | 0001437749-25-034437 |
| 10-Q | 30 Jun 2025 | 11 Aug 2025 | 42 days | 0001437749-25-025826 |
| 10-Q | 31 Mar 2025 | 14 May 2025 | 44 days | 0001437749-25-016831 |
| 10-K | 31 Dec 2024 | 26 Mar 2025 | 85 days | 0001437749-25-009397 |
| 10-Q | 30 Sep 2024 | 13 Nov 2024 | 44 days | 0001437749-24-034896 |
| 10-Q | 30 Jun 2024 | 13 Aug 2024 | 44 days | 0001437749-24-026310 |
| 10-Q | 31 Mar 2024 | 14 May 2024 | 44 days | 0001437749-24-016611 |
| 10-K | 31 Dec 2023 | 27 Mar 2024 | 87 days | 0001437749-24-009587 |
| 10-Q | 30 Sep 2023 | 8 Nov 2023 | 39 days | 0001437749-23-030938 |
| 10-Q | 30 Jun 2023 | 9 Aug 2023 | 40 days | 0001437749-23-022780 |
| 10-Q | 31 Mar 2023 | 10 May 2023 | 40 days | 0001437749-23-013580 |
| 10-K | 31 Dec 2022 | 29 Mar 2023 | 88 days | 0001437749-23-008312 |
| 10-Q | 30 Sep 2022 | 9 Nov 2022 | 40 days | 0001437749-22-026591 |
| 10-Q | 30 Jun 2022 | 10 Aug 2022 | 41 days | 0001437749-22-019788 |
| 10-Q | 31 Mar 2022 | 11 May 2022 | 41 days | 0001437749-22-011905 |
| 10-K | 31 Dec 2021 | 29 Mar 2022 | 88 days | 0001437749-22-007544 |
| 10-Q | 30 Sep 2021 | 10 Nov 2021 | 41 days | 0001437749-21-026143 |
| 10-Q | 30 Jun 2021 | 12 Aug 2021 | 43 days | 0001437749-21-019540 |
| 10-Q | 31 Mar 2021 | 13 May 2021 | 43 days | 0001437749-21-011911 |
| 10-K | 31 Dec 2020 | 30 Mar 2021 | 89 days | 0001437749-21-007543 |
| 10-Q | 30 Sep 2020 | 10 Nov 2020 | 41 days | 0001437749-20-023294 |
| 10-Q | 30 Jun 2020 | 13 Aug 2020 | 44 days | 0001437749-20-017718 |
| 10-Q | 31 Mar 2020 | 15 May 2020 | 45 days | 0001437749-20-010860 |
| 10-K | 31 Dec 2019 | 9 Apr 2020 | 100 days | 0001437749-20-007405 |
| 10-Q | 30 Sep 2019 | 19 Nov 2019 | 50 days | 0001437749-19-023200 |
| 10-Q | 30 Jun 2019 | 14 Aug 2019 | 45 days | 0001437749-19-016798 |
| 10-Q | 31 Mar 2019 | 15 May 2019 | 45 days | 0001437749-19-010038 |
| 10-K | 31 Dec 2018 | 2 Apr 2019 | 92 days | 0001437749-19-006300 |
| 10-Q | 30 Sep 2018 | 8 Nov 2018 | 39 days | 0001437749-18-019949 |
| 10-Q | 30 Jun 2018 | 9 Aug 2018 | 40 days | 0001437749-18-015094 |
| 10-Q | 31 Mar 2018 | 10 May 2018 | 40 days | 0001437749-18-009379 |
| 10-K | 31 Dec 2017 | 16 Mar 2018 | 75 days | 0001437749-18-004870 |
| 10-Q | 30 Sep 2017 | 9 Nov 2017 | 40 days | 0001437749-17-018927 |
| 10-Q | 30 Jun 2017 | 14 Aug 2017 | 45 days | 0001437749-17-014692 |
| 10-Q | 31 Mar 2017 | 11 May 2017 | 41 days | 0001437749-17-008777 |
| 10-K | 31 Dec 2016 | 30 Mar 2017 | 89 days | 0001437749-17-005643 |
| 10-Q | 30 Sep 2016 | 17 Oct 2016 | 17 days | 0001136261-16-000628 |
| 10-Q | 30 Jun 2016 | 2 Aug 2016 | 33 days | 0001136261-16-000580 |
Source: SEC EDGAR company submissions for CIK 0000925741. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.